SCHEMBL4833201

SCHEMBL4833201

NCc1ccc(CC(=O)O)cc1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.47
HPGD P15428 4/20 0.47
HSD17B10 Q99714 4/20 0.47
GAA P10253 4/20 0.47
TSHR P16473 4/20 0.47
MAPT P10636 3/20 0.47
LMNA P02545 2/20 0.47
NFKB1 P19838 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
RGS12 O14924 1/20 0.47
POLB P06746 1/20 0.47
APEX1 P27695 1/20 0.47
THPO P40225 1/20 0.47
BLM P54132 1/20 0.47
GNAI1 P63096 1/20 0.47
PMP22 Q01453 1/20 0.47
HIF1A Q16665 1/20 0.47
SRD5A2 P31213 1/20 0.43
ALDH1A1 P00352 4/20 0.43
CA2 P00918 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20943390 0.88 HSD17B10 (0.46) KDM4EHPGDHSD17B10GAATSHR
SCHEMBL28091937 0.86 CA2 (0.46) KDM4EHPGDLMNANFKB1POLB
SCHEMBL28193128 0.86 CFD (0.43) KDM4EHPGDHSD17B10GAATSHR
SCHEMBL27809841 0.86 KDM4E (0.47) KDM4EHPGDHSD17B10GAATSHR
SCHEMBL15862189 0.83 GAA (0.52) KDM4EHPGDHSD17B10GAATSHR
SCHEMBL25564400 0.81 F10 (0.37) ALDH1A1
SCHEMBL5364637 0.80 ALDH1A1 (0.53) HPGDGAATSHRMAPTNFKB1
SCHEMBL154429 0.79 KDM4E (0.55) KDM4EHPGDHSD17B10GAATSHR
SCHEMBL4841378 0.79 CA2 (0.61) KDM4EHPGDHSD17B10GAATSHR
SCHEMBL28192545 0.79 KDM4E (0.47) KDM4EHPGDHSD17B10GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107522634-A Biaryl ureas carboxylic acid derivates or its salt and its production and use 复旦大学 2017-12-29 CN disclosed
CN-102746214-A Novel indoline compounds FOURNIER LAB SA 2012-10-24 CN disclosed
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
CN-101316852-A Inhibitors of serine proteases VERTEX PHARMA (US) 2008-12-03 CN disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed
CN-101184731-A Indoline compounds FOURNIER LAB SA (FR) 2008-05-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 KDM4E 1574/4885HPGD 3316/4885HSD17B10 691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.